Rare Disease Studies: Patient Centricity
Rare disease trials must be designed around a deep understanding of the patient journey. Engaging patients and advocacy groups, applying therapeutic expertise, and considering participation burden can help shape studies that are both meaningful and practical. A flexible, patient-centric approach helps identify the right investigators, streamline assessments, and create tailored trials that support enrolment and achievable study goals.